{"id":58377,"date":"2024-12-04T13:15:06","date_gmt":"2024-12-04T13:15:06","guid":{"rendered":"https:\/?p=58377"},"modified":"2024-12-04T13:15:06","modified_gmt":"2024-12-04T13:15:06","slug":"roivant-sciences-stock-forecast","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/","title":{"rendered":"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics"},"content":{"rendered":"

Roivant Sciences Ltd (ROIV)<\/a> has been a focal point for investors interested in the biotechnology sector.\u00a0 This article delves into the company\u2019s business model, recent stock performance, investor sentiment, and expert analysis to provide a comprehensive forecast.<\/p>\n

Is now the time to buy ROIV? Access our full analysis report here<\/a>, it\u2019s free.<\/p>\n

Recent Performance and Market Conditions:<\/h2>\n

Roivant Sciences Ltd\u2019s stock closed at $12.12, reflecting a 23.42% gain over the past year. Despite a slight dip of 0.58% in the last week, the stock showed resilience with a 0.44% increase over the past month. The company\u2019s return on equity of 128.96% and return on invested capital of 105.69% underscore strong management performance. However, negative cash flow and a high valuation on a price-to-free-cash-flow basis warrant cautious optimism.<\/p>\n

In the biotechnology sector<\/a>, broader market trends have been mixed. While the sector\u2019s one-month return is a positive 3.77%, it faces volatility, as seen in the one-week decline of 4.49%.<\/p>\n

\"Cyber<\/p>\n

Stock Target Advisor\u2019s Analysis on Roivant Sciences Ltd:<\/h2>\n

Stock Target Advisor\u2019s<\/a> analysis of Roivant Sciences Ltd is bullish, driven by eight positive signals against two negative ones.\u00a0 The projected price change over the next 12 months is a substantial 46.45%, with a target price of $17.75.<\/p>\n

Analyst sentiment<\/a> around Roivant Sciences Ltd is overwhelmingly positive, with a “Strong Buy” rating on average. Of the five analysts covering the stock, their average target price stands at $18.07, with a range between $12.50 and $22.00.<\/p>\n

Recently, firms such as H.C. Wainwright<\/a> and Roth Capital Partners<\/a> have reiterated their buy recommendations, signaling strong institutional confidence in the company\u2019s growth potential.<\/p>\n

\"\"<\/a><\/p>\n

Conclusion:<\/h2>\n

Roivant Sciences Ltd (ROIV) emerges as a promising stock in the biotechnology sector, and strong market positioning. Despite certain valuation concerns, its performance metrics and bullish analyst sentiment position it as an attractive investment opportunity.<\/p>\n","protected":false},"excerpt":{"rendered":"

Roivant Sciences Ltd (ROIV) has been a focal point for investors interested in the biotechnology sector.\u00a0 This article delves into the company\u2019s business model, recent…<\/p>\n","protected":false},"author":17,"featured_media":57976,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58377","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nRoivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics<\/title>\n<meta name=\"description\" content=\"Discover the latest Roivant Sciences Ltd (ROIV) stock forecast, analyzing growth potential, analyst ratings, and market trends in the biotech sector\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics\" \/>\n<meta property=\"og:description\" content=\"Discover the latest Roivant Sciences Ltd (ROIV) stock forecast, analyzing growth potential, analyst ratings, and market trends in the biotech sector\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-04T13:15:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/11\/STAs-Blog-Images-2024-11-27T171539.731.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Muzzammil Ahmad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/x.com\/Muzzammil625\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Muzzammil Ahmad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\"},\"author\":{\"name\":\"Muzzammil Ahmad\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\"},\"headline\":\"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics\",\"datePublished\":\"2024-12-04T13:15:06+00:00\",\"dateModified\":\"2024-12-04T13:15:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\"},\"wordCount\":305,\"commentCount\":205,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\",\"name\":\"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-12-04T13:15:06+00:00\",\"dateModified\":\"2024-12-04T13:15:06+00:00\",\"description\":\"Discover the latest Roivant Sciences Ltd (ROIV) stock forecast, analyzing growth potential, analyst ratings, and market trends in the biotech sector\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\",\"name\":\"Muzzammil Ahmad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"caption\":\"Muzzammil Ahmad\"},\"description\":\"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/\",\"https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625\"],\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics","description":"Discover the latest Roivant Sciences Ltd (ROIV) stock forecast, analyzing growth potential, analyst ratings, and market trends in the biotech sector","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/","og_locale":"en_US","og_type":"article","og_title":"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics","og_description":"Discover the latest Roivant Sciences Ltd (ROIV) stock forecast, analyzing growth potential, analyst ratings, and market trends in the biotech sector","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-12-04T13:15:06+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/11\/STAs-Blog-Images-2024-11-27T171539.731.png","type":"image\/png"}],"author":"Muzzammil Ahmad","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/x.com\/Muzzammil625","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Muzzammil Ahmad","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/"},"author":{"name":"Muzzammil Ahmad","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8"},"headline":"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics","datePublished":"2024-12-04T13:15:06+00:00","dateModified":"2024-12-04T13:15:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/"},"wordCount":305,"commentCount":205,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/","name":"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-12-04T13:15:06+00:00","dateModified":"2024-12-04T13:15:06+00:00","description":"Discover the latest Roivant Sciences Ltd (ROIV) stock forecast, analyzing growth potential, analyst ratings, and market trends in the biotech sector","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/roivant-sciences-stock-forecast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Roivant Sciences Stock Forecast: Bullish Trends and Key Performance Metrics"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8","name":"Muzzammil Ahmad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","caption":"Muzzammil Ahmad"},"description":"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.","sameAs":["https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/","https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625"],"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/58377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=58377"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/58377\/revisions"}],"predecessor-version":[{"id":58381,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/58377\/revisions\/58381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/57976"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=58377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=58377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=58377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}